Interestingly, at an early healing stage the involvement of mechanisms associated to epigenetic processes has been recently described. 5 The introduction of changes in the level of histone methylation, 5 in fact, has been found to be associated with a loss of global inhibitory histone methylation, such as the trimethylation of histone H3 lysine 27 (H3K27me3). The downregulation of Polycomb group proteins paralleled by upregulation of histone demethylases has been reported at the basis of this process determining a wide enrichment in potential accessible chromatin in
In physiopathological conditions, such as diabetes, wound healing is significantly compromised and chronic complications, including ulcers, may occur. In a mouse model of skin repair, we recently reported that wound treatment with Sirtuin activators and class I HDAC inhibitors induced keratinocyte proliferation and enhanced healing via a nitric oxide (NO) dependent mechanism. We observed an increase in total protein acetylation in the wound area, as determined by acetylation of α-tubulin and histone H3 Lysine 9. We reasoned that this process activated cell function as well as regulated gene expression to foster tissue repair. We report here that the direct activation of P300/CBP-associated factor (PCAF) by the histone acetylase activator pentadecylidenemalonate 1b (SPV-106) induced Lysine acetylation in the wound area. This intervention was sufficient to enhance repair process by a NO-independent mechanism. Hence, an impairment of PCAF and/or other GCN5 family acetylases may delay skin repair in physiopathological conditions. Keywords: Lysine acetylation, epigenetics, PCAF, wound healing, nitric oxide, keratinocyte skin fibroblast and keratinocytes, 5 that it is supposed to positively contribute to skin repair during the early healing stages. The presence of an accessible chromatin, together with post-transduction modifications introduced in transcription factors and structural proteins may, in fact, provide specific signals required by an active tissue repair process. Remarkably, it is this specific condition that could be of interest for the identification of drugs relevant to the amelioration of ulcer healing.
Enhancement of lysine acetylation accelerates wound repair
A simple model to investigate skin repair at molecular level is represented by the skin punch biopsy realized in rodents. A full-thickness punch of about 3 mm is surgically created on the back of mice or rats and its spontaneous healing process can be followed until closure, which typically occurs in about 2 weeks. This simple model allows the comparison of different treatments directly applied on the site of the wound. [6] [7] [8] By using this approach, we recently demonstrated the functional cross-talk between class I HDACs and Sirtuins, mediated by nitric oxide (NO), and necessary for skin repair. 9 A body of evidence, in fact, assigns to NO a functional relevance in all 4 phases of wound repair 10, 11 and several therapeutic approaches for chronic ulcers were recently focused on devices able to release constant NO levels in the wound site. 12, 13 The mechanism of NO action, however, is still poorly characterized and the pleiotropic properties of this gaseous molecule make it difficult to clearly understand its effect at cellular and molecular level. In our prior work, we reported pentadecylidenemalonate 1b (SPV-106), 15 a HAT activator, was directly applied on wounded mouse skin. This treatment significantly accelerated skin repair compare to vehicle-treated animals and those exposed to the HAT inhibitor Anacardic Acid (Fig. 1A and B) . 16 Intriguingly, the SPV-106 compound induced in vivo histone acetylation (Fig. 1C) without modification of NO levels, as determined by the fluorescence probe 4,5-diaminofluorescein (DAF-2 DA) in the human keratinocytes-derived HaCaT cells (Fig. 1D) . These results suggest that lysine acetylation occurs downstream of NO signaling and point out that epigenetic molecules able to activate HATs could be important in tissue repair.
Although little is known about the role of acetylases during wound healing, and specifically that of PCAF, this enzyme seems important for keratinocyte activation and differentiation by a mechanism which involves Rb. 17 In conclusion, our work reports the unprecedented evidence that HAT activators, similarly to HDAC inhibitors, promote acetylation in the wound site and accelerate repair.
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No potential conflicts of interest were disclosed. that local applications of Thricostatin A (TSA), a pan HDAC inhibitor (HDACi), significantly enhanced lysine acetylation in activated keratinocytes resident in the wound. 9 This effect led to an accelerated wound closure, which was obtained also by using the class I selective HDAC inhibitor MS275.
14 On the other hand, Sirtuin activators accelerated wound closure, as well, suggesting that different types of epigenetic molecules involved in the regulation of lysine acetylation could be relevant for the amelioration of the repair process. 9 Hence, an increase in total protein acetylation, including that of histones, transcript factors, and structural protein, may be necessary to promote those changes in gene expression, cell growth and motility that occur during the epigenetic reprogramming that follows wound healing. The acetylation of α-Tubulin for instance seems involved in the regulation of cell motility and uptake of external substances, which may be important during the early phases of keratinocyte and/or other skin cell responses to acute damage. Nonetheless, changes in the structure of chromatin as those determined by histone Lysine acetylation may have an important inference on gene expression as described in our prior work. 9 In this light, experiments were performed in which the p300/ CREB binding protein-associated factor (PCAF) activator for Scientific and Economic Excellence and by LOEWE-CGT Frankfurt: funding reference number: III L 4-518/17.004 (2010 to FS).
